{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:28Z","timestamp":1790975128752,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.vaccine.2004.11.044","type":"journal-article","created":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T22:58:50Z","timestamp":1102633130000},"page":"2762-2774","source":"Crossref","is-referenced-by-count":76,"title":["Policymakers\u2019 views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia"],"prefix":"10.1016","volume":"23","author":[{"given":"Denise","family":"DeRoeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nyamete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2004.11.044_bib1","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull WHO"},{"issue":"5","key":"10.1016\/j.vaccine.2004.11.044_bib2","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull WHO"},{"issue":"2","key":"10.1016\/j.vaccine.2004.11.044_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2310\/7060.2001.24300","article-title":"Cholera vaccines","volume":"8","author":"Ryan","year":"2001","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2004.11.044_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s100960050361","article-title":"Experience with Salmonella typhi Vi capsular polysaccharride vaccine","volume":"18","author":"Hessel","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2004.11.044_bib5","first-page":"957","article-title":"Vaccination against typhoid fever: present status","volume":"72","author":"Ivanoff","year":"1994","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2004.11.044_bib6","first-page":"839","article-title":"Typhoid fever","author":"Levine","year":"1998"},{"issue":"1","key":"10.1016\/j.vaccine.2004.11.044_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/infdis\/158.1.60","article-title":"Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.11.044_bib8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","article-title":"Protective efficacy of the oral, whole cell\/recombinant B subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.11.044_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2004.11.044_bib10","first-page":"373","article-title":"Construction and characteristic of an attenuated Shigella flexneri 2a\/Shigella sonnei bivalent vaccine","volume":"7","author":"Wang","year":"1987","journal-title":"J Chin Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2004.11.044_bib11","first-page":"178","article-title":"Double-blind field trial of oral live F2a-Sonnei (FS) dysentery vaccine","volume":"12","author":"Tu","year":"1999","journal-title":"J Biol Prod"},{"issue":"7","key":"10.1016\/j.vaccine.2004.11.044_bib12","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.11.044_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomized efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.11.044_bib14","unstructured":"World Health Organization. Vaccine research and development: new strategies for accelerating Shigella vaccine development. Wkly Epidemiol Rec 1997;72(11):73\u20139."},{"issue":"10","key":"10.1016\/j.vaccine.2004.11.044_bib15","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/IAI.59.10.3610-3618.1991","article-title":"Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine","volume":"59","author":"Levenson","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.11.044_bib16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0264-410X(99)00269-8","article-title":"Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four \u2018newly adopting\u2019 countries","volume":"18","author":"Wenger","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.11.044_bib17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0264-410X(98)00246-1","article-title":"The introduction of new vaccines in developing countries","volume":"17","author":"Mahoney","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.11.044_bib18","unstructured":"Madrid MY. The introduction and use of new vaccines in the public and private sectors: Thailand (draft report). Geneva, Switzerland: World Health Organization, Global Programme on Vaccines and Immunization; 1998."},{"key":"10.1016\/j.vaccine.2004.11.044_bib19","unstructured":"Madrid MY. The introduction and use of new vaccines in the public and private sectors: Morocco (draft report). Geneva, Switzerland: World Health Organization, Global Programme on Vaccines and Immunization; 1998."},{"key":"10.1016\/j.vaccine.2004.11.044_bib20","unstructured":"Madrid MY. Summary of three country studies on the introduction of new vaccines (Morocco, Thailand, Zimbabwe) (draft report). Geneva, Switzerland: World Health Organization, Global Programme on Vaccines and Immunization; 1998."},{"key":"10.1016\/j.vaccine.2004.11.044_bib21","unstructured":"Princeton Survey Research Associates. Benchmark surveys on childhood immunization in Thailand, Nepal, Zimbabwe and Tanzania (draft report). Washington, DC: Princeton Survey Research Associates; 1999."},{"issue":"4","key":"10.1016\/j.vaccine.2004.11.044_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/clinids\/9.4.841","article-title":"Control of typhoid fever in Bangkok Thailand by annual immunization of school children with parenteral typhoid vaccine","volume":"9","author":"Bodhidatta","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2004.11.044_bib23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.11.044_bib24","unstructured":"Levin A, Howlader S, Ram S, Siddiqui SM, Razul I, Routh S. Case study on the costs and financing of immunization services in Bangladesh. Special initiatives report no. 21. Bethesda, MD: Partnerships for Health Reform Project, Abt Associates Inc.; 1999."},{"issue":"8523","key":"10.1016\/j.vaccine.2004.11.044_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(87)90714-8","article-title":"Oral rehydration solution: too little or too much?","volume":"1","author":"Stanton","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.11.044_bib26","unstructured":"Ramachandran P, Singh M, Kapoor AN, Lamba KK, Savitri R, Das, AC. Health, nutrition and family welfare programme review of progress during the ninth plan period. New Delhi, India: Planning Commission, Government of India; February 2001."},{"key":"10.1016\/j.vaccine.2004.11.044_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(03)00533-4","article-title":"Policymakers\u2019 views on dengue fever\/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries","volume":"22","author":"DeRoeck","year":"2003","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2004.11.044_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4269\/ajtmh.2004.71.248","article-title":"Policy challenges in malaria vaccine introduction","volume":"71","author":"Moree","year":"2004","journal-title":"Am J Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04008886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04008886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T16:17:33Z","timestamp":1586017053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04008886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":28,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0264410X04008886"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.11.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}